What’s new in invasive pulmonary aspergillosis in the critically ill

[1] Koulenti D(2014)Approach to invasive pulmonary aspergillosis in critically ill patients Curr Opin Infect Dis 27 174-183

[2] Garnacho-Montero J(2008)Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Clin Infect Dis 46 1813-1821

[3] Blot S(2013)Aspergillosis in intensive care unit (ICU) patients: epidemiology and economic outcomes BMC Infect Dis 13 29-1768

[4] De Pauw B(2012)Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study Intensive Care Med 38 1761-257

[5] Walsh TJ(2004)Invasive aspergillosis in ICU patients: analysis of risk factors for acquisition and mortality Acta Clin Belg 59 251-1184

[6] Donnelly JP(2008)Factors associated with overall and attributable mortality in invasive aspergillosis Clin Infect Dis 47 1176-64

[7] Stevens DA(2012)A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients Am J Respir Crit Care Med 186 56-1405

[8] Edwards JE(2006)Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients Crit Care 10 R31-34

[9] Calandra T(2013)Fungal sepsis in the ICU: are we doing better? Trends in incidence, diagnosis, and outcome Minerva Anestesiol 79 1396-1060

[10] Pappas PG(2013)Are we there yet? Recent progress in the molecular diagnosis and novel antifungal targeting of PLoS Pathog 9 e1003642-731

[1] Koulenti D(2014)Approach to invasive pulmonary aspergillosis in critically ill patients Curr Opin Infect Dis 27 174-183

[2] Garnacho-Montero J(2008)Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group Clin Infect Dis 46 1813-1821

[3] Blot S(2013)Aspergillosis in intensive care unit (ICU) patients: epidemiology and economic outcomes BMC Infect Dis 13 29-1768

[4] De Pauw B(2012)Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study Intensive Care Med 38 1761-257

[5] Walsh TJ(2004)Invasive aspergillosis in ICU patients: analysis of risk factors for acquisition and mortality Acta Clin Belg 59 251-1184

[6] Donnelly JP(2008)Factors associated with overall and attributable mortality in invasive aspergillosis Clin Infect Dis 47 1176-64

[7] Stevens DA(2012)A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients Am J Respir Crit Care Med 186 56-1405

[8] Edwards JE(2006)Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients Crit Care 10 R31-34

[9] Calandra T(2013)Fungal sepsis in the ICU: are we doing better? Trends in incidence, diagnosis, and outcome Minerva Anestesiol 79 1396-1060

[10] Pappas PG(2013)Are we there yet? Recent progress in the molecular diagnosis and novel antifungal targeting of PLoS Pathog 9 e1003642-731